General
Health Ministry Proposes New Rules for Antimicrobials and Bulk Drugs
Reported by Kavya Rao (Senior Writer) · The Hindu - National ·
The Union Health Ministry has proposed key changes to tighten the control over antimicrobials and bulk drugs in the country. ## New Rules The draft amendments will add antimicrobials to the definition of a 'New Drug' under the New Drugs and Clinical Trials Rules of 2019. This step aims to fix gaps where companies got manufacturing licences without enough regulatory checks like stability and bioavailability tests. Makers will now need permission from the Central Licensing Authority before they apply for a state licence. ## Bulk Drug Sales The Ministry also proposed changes to the Drugs Rules of 1945 to create separate application and licence forms, specifically Form 19-BC and Form 20-BC, for the wholesale sale of bulk drugs. Right now, a single common licence covers both finished medicines and raw bulk substances. The new system will track bulk drug categories, including items under the NDPS Act of 1985, and require a competent person to supervise the sales directly. These proposals were approved by the Drugs Consultative Committee on November 17, 2025, and the Drugs Technical Advisory Board on February 16, 2026. ## Context Antimicrobial resistance happens when germs like bacteria change and stop responding to the medicines designed to kill them, making common infections harder to treat. Strict regulatory oversight on how these medicines are made and sold helps protect public health by reducing misuse. Public and expert feedback has been invited on these proposed draft rules before they are finalized.
More in General
GeneralSource: The HinduWorth knowing
Bihar Chief Minister Samrat Choudhary plans statewide tour starting November 26
Reported by Rituparna Sen (Section Editor) · The Hindu - National ·
